An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Peter Langmuir
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Catholic University of Korea, Seoul St. Mary'S Hospital, 222 Banpo-Daero
Seoul, Seocho-gu, South Korea
- Severance Hospital, Yonsei University Health System 50-1 Yonsei-Ro
Seoul, Seodaemun-gu, South Korea
- Asan Medical Center Department of Oncology, 88, Olympic-Ro 43-Gil
Seoul, Songpa-gu, South Korea
- Antiga Guarderia-Servei D'Oncologia Hospital Vall D'Hebron. P.Vall Hebron 119-129
Barcelona, Spain
- Hospital Ramón Y Cajal Ctra. Colmenar Viejo Km. 9,1 Planta (-)2 Dcha Oficina de Ensayos Clínicos Servicio de Oncología Médica
Madrid, Spain
- Hospital Clinico Universitario Valencia Avenida Blasco Ibáñez 17 -8º
Valencia, Spain
- Taipei Veterans General Hospital, No.201 Sec. 2 Shipai Rd L
Taipei, Beitou District, Taiwan
- National Taiwan University Hospital, 7 Zhongshan South Road
Taipei, Zhongzheng District, Taiwan
- University of California San Diego, 3855 Health Sciences Drive, Mc 0987
La Jolla, California, United States
- University California San Francisco Thoracic Surgery and Oncology Clinic, 1600 Divisadero Street, Floor 4
San Francisco, California, United States
- Innovative Clinical Research Institute, 15111 Whittier Blvd., Suite 216
Whittier, California, United States
- Rocky Mountain Cancer Center, 1800 Williams Street, Suite 200
Denver, Colorado, United States
- Georgetown University Hospital, 3800 Reservoir Rd, Nw
Washington D.C., District of Columbia, United States
- Lynn Cancer Center, 701 Nw 13th Street, Floor 2
Boca Raton, Florida, United States
- Dana-Farber Cancer Institute, 450 Brookline Avenue
Boston, Massachusetts, United States
- Henry Ford Health System, 2799 W Grand Blvd.
Detroit, Michigan, United States
- Karmanos Cancer Institute, 4100 John R. Street Mail Code Hw04ho
Detroit, Michigan, United States
- Valley Hospital, 223 N Van Dien Avenue
Ridgewood, New Jersey, United States
- Nyu Langone Medical Center, 160 East 34th Street, Floor 8
New York, New York, United States
- Stony Brook University Medical Center, 3 Edmund D. Pellegrino Road
Stony Brook, New York, United States
- Cleveland Clinic, 9500 Euclid Avenue, G Building
Cleveland, Ohio, United States
- Earle A. Chiles Research Institute Providence Cancer Center, 4805 Ne Glisan Street, 2n35
Portland, Oregon, United States
- St. Luke'S University Health Network, 701 Ostrum Street, Suite 403
Fountain Hill, Pennsylvania, United States
- Thomas Jefferson University, 111 S. 11th Street
Philadelphia, Pennsylvania, United States
- Texas Oncology - South Austin, 901 West 38th Street, Suite 200
Austin, Texas, United States
- University of Texas -Md Anderson Cancer Center, 1515 Holcombe Blvd.
Houston, Texas, United States
- Texas Oncology - San Antonio Medical, 5206 Research Drive
San Antonio, Texas, United States
- Texas Oncology-Tyler, 910 E Houston Street, Suite 100
Tyler, Texas, United States
- Huntsman Cancer Institute, 2000 Circle of Hope Drive
Salt Lake City, Utah, United States
- Us Oncology-Virginia Cancer Specialists, Pc, 8503 Arlington Blvd., Suite 400
Fairfax, Virginia, United States
- West Virginia University Cancer Institute, 1 Medical Center Drive
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Dec 2016
- Primary completion
- 24 Dec 2025
- Completion
- 24 Dec 2025
- Last update posted
- 9 Feb 2026
- Registered enrollment
- 59
- Registry id
- NCT02917993
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.